TriSalus Life Sciences, Inc. (TLSI): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$18.93M
Year ended 2025-12-31
-$23.28M
Trailing 12 months to 2026-06-30
2022-12-31: -$32.97M2023-12-31: -$51.17M2024-12-31: -$41.19M2025-12-31: -$18.93M-$18.93M
2022-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$18.93Mn/m2026-03-05, From 2025-01-01
2024-12-31-$41.19Mn/m2026-03-05, From 2024-01-01
2023-12-31-$51.17Mn/c2025-05-30, From 2023-01-01
2022-12-31-$32.97Mn/a2024-04-11, From 2022-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
TriSalus Life Sciences, Inc. (TLSI)2025-12-31-$18.93Mn/m
SANUWAVE Health, Inc. (SNWV)2025-12-31$1.93M-1.6%
Shoulder Innovations, Inc. (SI)2025-12-31-$36.02Mn/m
SS Innovations International, Inc. (SSII)2025-12-31-$22.20Mn/m
KORU Medical Systems, Inc. (KRMD)2025-12-31-$470.1Kn/m
Carlsmed, Inc. (CARL)2025-12-31-$29.62Mn/m
Interpace Biosciences, Inc. (IDXG)2025-12-31$5.47M+45.2%
Apyx Medical Corp (APYX)2025-12-31-$9.12Mn/m
Utah Medical Products Inc (UTMD)2025-12-31$14.32M-1.9%

Compare TLSI, SNWV, SI, SSII side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗